Axorus

Company

At Axorus, we develop a Contact Lens to restore sight to blind patients afflicted by dry AMD or Retinitis Pigmentosa

With our partners at Boston University, we developed this retinal stimulator, using patented photoacoustic technology.

Preclinical trials are currently underway at the Institut de la Vision in Paris, France

Jean-Damien

CEO

Hélène, PhD

CTO

Yueming, PhD

Scientist

Julien

Material Engineer

Dr. Serge Picaud

Vision Institute Director

Pr. Ji-Xin Cheng

Photoacoustic Scientist

Pr. Chen Yang

Photoacoustic Scientist

Dr. Vasily Smirnov, MD

Neuro-ophthalmologist

Pr. Frédéric Matonti, MD

Ophthalmologist, Surgeon

We work in close collaboration with neurobiologists and regulatory affairs advisors.

We are developing a patented non-invasive Artificial Retina aimed at restoring sight for people with damaged retinas.

No surgery
No injections
No genetherapy

We are using genetic-free photoacoustic neuromodulation to stimulate cells inside the retina in order to restore vision for the patients.

We have preclinical proof of in vivo non-invasive photoacoustic activation of the retina and visual areas of the brain.

The published proof of concept results below were obtained with an invasive version (retinal implant) of the same technology.

You are looking for a start-up that tackles challenging and meaningful projects :
Join Us - send your resume to jobs@axorus.com

Axorus SAS - RCS Lille Metropole 853 802 494